Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 1230Neoplasms 1040Carcinoma, Non-Small-Cell Lung 757Prostatic Neoplasms 697Colorectal Neoplasms 598Lung Neoplasms 578Pancreatic Neoplasms 403Leukemia, Myeloid, Acute 399Neoplasm Metastasis 391Ovarian Neoplasms 373Multiple Myeloma 373Stomach Neoplasms 319Carcinoma, Hepatocellular 304Melanoma 284Brain Neoplasms 281Recurrence 280Squamous Cell Carcinoma of Head and Neck 269Head and Neck Neoplasms 240Endometrial Neoplasms 236Glioblastoma 235Triple Negative Breast Neoplasms 230Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Lymphoma 226Uterine Cervical Neoplasms 225Sarcoma 202Hematologic Neoplasms 201Urinary Bladder Neoplasms 197Esophageal Neoplasms 192Carcinoma, Renal Cell 191Lymphoma, Non-Hodgkin 177

Interventions

Multiparametric Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Urothelial Bladder Cancer × 1 year × Clear all
NCT06335667 2026-05-04

mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

University of California, Irvine

Phase NA Recruiting
30 enrolled
Genitourinary

Urothelial Bladder Cancer

NCT04428554 2025-11-18

BLAD-RAD01

Institut Claudius Regaud

Phase 2 Recruiting
130 enrolled
Genitourinary

Urothelial Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡